|
시장보고서
상품코드
2078898
백혈병 스크리닝 시장 : 검사 유형별, 질환 유형별, 연령층별, 최종사용자별, 지역별Leukemia Screening Market, By Test Type, By Disease Type, By Age Group, By End User, By Geography |
||||||
백혈병 스크리닝 시장은 2026년에 89억 4,000만 달러, 2033년까지 145억 5,000만 달러에 이를 것으로 예상됩니다. 또한, 2026-2033년 CAGR 7.2%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 89억 4,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 7.20% | 2033년 시장 규모 예측 : | 145억 5,000만 달러 |
백혈병은 혈액 세포에 영향을 미치는 암의 일종입니다. 이는 심각한 질병이며, 많은 사망자를 발생시키고 있어 가족과 의료 시스템에 막대한 부담을 주고 있습니다. 백혈병의 주요 진단 방법은 임상 검사와 신체 검사입니다. 전혈구계수(CBC) 검사에서는 체내의 적혈구, 백혈구, 혈소판 수를 확인합니다. 백혈구 수가 비정상적으로 많은 경우, 백혈병의 징후일 가능성이 있습니다. 백혈병 세포 중에는 혈액 속을 순환하는 것도 있고, 골수에 머물러 있어 일반적인 혈액 검사로는 발견되지 않는 것도 있습니다. 전 세계적으로 다양한 유형의 백혈병 발병률이 증가하고 있는 가운데, 세계 백혈병 스크리닝 시장은 최근 몇 년간 눈부신 성장을 이루고 있습니다. 백혈병은 골수에서 발생하며, 비정상적인 백혈구가 대량으로 증식하는 혈액암의 일종입니다. 전 세계적인 환경 오염의 심화, 생활 습관의 변화, 그리고 인구 고령화에 따라 백혈병 환자 수는 꾸준히 증가하고 있습니다. 그 결과, 선진국과 개발도상국 모두에서 백혈병의 조기 발견을 목적으로 하는 정밀 선별 검사에 대한 수요가 증가하고 있습니다. 백혈병에 대한 인식을 높이고 혁신적인 선별 검사 솔루션의 보급을 목표로 하는 공공 및 민간을 막론한 다양한 노력들이 전 세계 백혈병 스크리닝 산업을 더욱 뒷받침하고 있습니다.
시장 역학:
레지오넬라균 및 폐렴 관련 질환의 유병률 증가, 신속하고 정밀한 진단법에 대한 수요 증가, 세균 검사 기술의 발전 등의 요인으로 인해 시장은 현저히 확대되고 있습니다. 레지오넬라 폐렴은 지역사회 획득성 폐렴의 비교적 드문 원인 중 하나입니다. 예를 들어, 2022년 11월에 발표된 “Community-Acquired Pneumonia”라는 제목의 연구에 따르면, 지역사회 획득성 폐렴의 전 세계 추정 발생률은 지역, 계절, 인구 특성에 따라 다르지만, 연간 1,000명당 1.5-14건인 것으로 나타났습니다. 유병률은 나이가 들수록 증가하며, 미국에서는 성인 1만 명당 연간 24.8건입니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 백혈병 스크리닝 시장의 주요 기업 프로파일을 소개했습니다.
- 본 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 세계 백혈병 스크리닝 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 백혈병 스크리닝 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 백혈병 검진
제5장 세계의 백혈병 스크리닝 시장 : 테스트 유형별, 2021년-2033년
제6장 세계의 백혈병 스크리닝 시장 : 질환 유형별, 2021년-2033년
제7장 세계의 백혈병 스크리닝 시장 : 연령층별, 2021년-2033년
제8장 세계의 백혈병 스크리닝 시장 : 최종사용자별, 2021년-2033년
제9장 세계의 백혈병 스크리닝 시장 : 지역별, 2021년-2033년
제10장 경쟁 구도
제11장 섹션
LSH 26.07.10Leukemia Screening Market is estimated to be valued at USD 8.94 Bn in 2026 and is expected to reach USD 14.55 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 8.94 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.20% | 2033 Value Projection: | USD 14.55 Bn |
Leukemia is a type of cancer that affects blood cells. It is a serious condition that causes a high number of deaths, thereby creating a huge burden on families and the healthcare system. The main diagnostic tools for leukemia are laboratory tests and a physical exam. A complete blood count (CBC) checks the levels of red and white blood cells and platelets in the body. A high level of abnormal white cells can indicate leukemia. Some types of leukemia cells circulate in the blood, while others stay in the bone marrow and do not show up in a routine blood test. The global leukemia screening market has been witnessing notable growth over the past few years due to the rising incidence of different types of leukemia across the world. Leukemia is a type of blood cancer that starts in the bone marrow and results in a high number of abnormal white blood cells. There has been steady rise in leukemia cases due to growing environmental pollution, changing lifestyle habits, and increasing age of the population globally. As a consequence, demand for advanced screening tests for early detection of leukemia has increased in both developed and developing nations. Various public and private initiatives aimed at enhancing awareness about leukemia and availability of innovative screening solutions has further propelled the global leukemia screening industry.
Market Dynamics:
The market is expanding significantly as a result of factors such the increased prevalence of illnesses linked to legionella and pneumonia, as well as the growing need for quick, sophisticated diagnostic methods and developments in bacterial testing technology. A comparatively rare cause of community-acquired pneumonia is legionella pneumonia. For instance, in November 2022, according to a study published titled Community-Acquired Pneumonia, the expected global incidence of community-acquired pneumonia ranges from 1.5 to 14 cases per 1000 person each year, with region, season, and population characteristics all having a part. Incidence rates rise with age, with 24.8 instances per 10,000 adults in the U.S. each year.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global leukemia screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., QIAGEN N.V., Beckman Coulter, Inc., Adaptive Biotechnologies Corporation, Invivoscribe, Inc., and ArcherDX, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global leukemia screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leukemia screening market
Detailed Segmentation:
- By Test Type (Revenue, USD Bn, 2021 - 2033)
- Complete Blood Count (CBC)
- Bone Marrow Aspiration and Biopsy
- Flow Cytometry
- Cytogenetic Analysis
- Polymerase Chain Reaction (PCR)
- Immunophenotyping
- Others
- By Disease Type (Revenue, USD Bn, 2021 - 2033)
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Others
- By Age Group (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adult
- Geriatric
- By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in the Global Leukemia Screening Market:
- F.Hoffmann-La Roche Ltd*
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- QIAGEN N.V.
- Beckman Coulter, Inc.
- Adaptive Biotechnologies Corporation
- Invivoscribe, Inc.
- ArcherDX, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By Disease Type
- Market Snippet, By Age Group
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing incidence of leukemia
- High cost of screening procedures
- Expansion in emerging markets
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Leukemia Screening
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Leukemia Screening Market, By Test Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Complete Blood Count (CBC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Bone Marrow Aspiration and Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Flow Cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Cytogenetic Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Immunophenotyping
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Leukemia Screening Market, By Disease Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Acute Lymphoblastic Leukemia (ALL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn )
- Acute Myeloid Leukemia (AML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn )
- Chronic Lymphocytic Leukemia (CLL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn )
- Chronic Myeloid Leukemia (CML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn )
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn )
7. Global Leukemia Screening Market, By Age Group, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn )
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn )
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn )
8. Global Leukemia Screening Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn )
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn )
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
9. Global Leukemia Screening Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022€"2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
- South Africa
- Central Africa
- North Africa
10. Competitive Landscape
- Company Profile
- F.Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Beckman Coulter, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Adaptive Biotechnologies Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Invivoscribe, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ArcherDX, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- F.Hoffmann-La Roche Ltd
- Analyst Views
11. Section
- References
- Research Methodology
- About us
